These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6119567

  • 21. Magic mushrooms: hope for a 'cheap high' resulting in end-stage renal failure.
    Franz M, Regele H, Kirchmair M, Kletzmayr J, Sunder-Plassmann G, Hörl WH, Pohanka E.
    Nephrol Dial Transplant; 1996 Nov; 11(11):2324-27. PubMed ID: 8941602
    [No Abstract] [Full Text] [Related]

  • 22. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.
    Beck O, Helander A, Karlson-Stiber C, Stephansson N.
    J Anal Toxicol; 1998 Nov; 22(1):45-9. PubMed ID: 9491968
    [Abstract] [Full Text] [Related]

  • 23. The pharmacology of psilocybin.
    Passie T, Seifert J, Schneider U, Emrich HM.
    Addict Biol; 2002 Oct; 7(4):357-64. PubMed ID: 14578010
    [Abstract] [Full Text] [Related]

  • 24. Illicit drug use among Canadian youth. I.
    Unwin JR.
    Can Med Assoc J; 1968 Feb 24; 98(8):402-7. PubMed ID: 4866088
    [No Abstract] [Full Text] [Related]

  • 25. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME, Portier CB, Franssen EJ.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2869-72. PubMed ID: 18257429
    [Abstract] [Full Text] [Related]

  • 26. Psilocybin--summary of knowledge and new perspectives.
    Tylš F, Páleníček T, Horáček J.
    Eur Neuropsychopharmacol; 2014 Mar 29; 24(3):342-56. PubMed ID: 24444771
    [Abstract] [Full Text] [Related]

  • 27. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J, Winstock A, Hunt N, Mitcheson L.
    Eur Addict Res; 2007 Mar 29; 13(1):57-64. PubMed ID: 17172780
    [Abstract] [Full Text] [Related]

  • 28. Harm potential of magic mushroom use: a review.
    van Amsterdam J, Opperhuizen A, van den Brink W.
    Regul Toxicol Pharmacol; 2011 Apr 29; 59(3):423-9. PubMed ID: 21256914
    [Abstract] [Full Text] [Related]

  • 29. An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.
    Casale JF.
    J Forensic Sci; 1985 Jan 29; 30(1):247-50. PubMed ID: 4038992
    [Abstract] [Full Text] [Related]

  • 30. [COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].
    KANDIC B, DORDEVIC D.
    Vojnosanit Pregl; 1963 May 29; 20():275-9. PubMed ID: 14067329
    [No Abstract] [Full Text] [Related]

  • 31. Drugs, youth and health education.
    Stacey B, Wells B.
    Health Bull (Edinb); 1974 Sep 29; 32(5):216-21. PubMed ID: 4443249
    [No Abstract] [Full Text] [Related]

  • 32. Drug abuse in Slovak Republic.
    Kresanek J, Plackova S, Caganova B, Klobusicka Z.
    Przegl Lek; 2005 Sep 29; 62(6):357-60. PubMed ID: 16225068
    [Abstract] [Full Text] [Related]

  • 33. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M, Bala A.
    Psychiatr Pol; 2013 Sep 29; 47(6):1157-67. PubMed ID: 25007546
    [Abstract] [Full Text] [Related]

  • 34. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF, Ravn HB, Lassen SF.
    Ugeskr Laeger; 1990 Jan 29; 152(5):314-7. PubMed ID: 2301080
    [Abstract] [Full Text] [Related]

  • 35. Psilocybin for treating substance use disorders?
    de Veen BT, Schellekens AF, Verheij MM, Homberg JR.
    Expert Rev Neurother; 2017 Feb 29; 17(2):203-212. PubMed ID: 27684102
    [Abstract] [Full Text] [Related]

  • 36. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.
    Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J.
    J Psychoactive Drugs; 2022 Feb 29; 54(4):324-327. PubMed ID: 35083957
    [No Abstract] [Full Text] [Related]

  • 37. [American magical plants (Psylocybe--Stropharia--Anhalonium)].
    Bernabai A.
    Ann Sanita Pubblica; 1966 Feb 29; 27(6):1265-96. PubMed ID: 5985616
    [No Abstract] [Full Text] [Related]

  • 38. Abuse of psychotomimetics.
    Jorgensen F.
    Acta Psychiatr Scand Suppl; 1968 Feb 29; 203():205-16. PubMed ID: 5248231
    [No Abstract] [Full Text] [Related]

  • 39. [Levels of psilocybin and psilocin in various types of mushrooms].
    Stríbrný J, Borovicka J, Sokol M.
    Soud Lek; 2003 Jul 29; 48(3):45-9. PubMed ID: 14631713
    [Abstract] [Full Text] [Related]

  • 40. Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.
    McDonald A.
    Can J Psychiatry; 1980 Nov 29; 25(7):586-94. PubMed ID: 6777029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.